Prevalence of antimicrobial-resistant bacteria isolated from older versus younger hospitalized adults: Results of a two-centre study

Journal of Antimicrobial Chemotherapy

Volumn 64, Issue 6, 2009, Pages 1291-1298

  Weber, Stephen G ^a   Miller, Ram R ^b   Perencevich, Eli N ^b,c   Tolentino, Jocelyn ^a   Meltzer, David ^a   Pitrak, David ^a   McGregor, Jessina C ^d   Sachs, Greg A ^e   Harris, Anthony D ^b   Furuno, Jon P ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d OREGON STATE UNIVERSITY   (United States)

^e INDIANA UNIVERSITY CENTER FOR AGING RESEARCH   (United States)

Author keywords

Age; Bacterial; Drug resistance

Indexed keywords

ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; GATIFLOXACIN; IMIPENEM; LEVOFLOXACIN; METICILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ADULT; AGE; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLOOD CULTURE; CONTROLLED STUDY; ESCHERICHIA COLI; HOSPITAL PATIENT; HUMAN; KLEBSIELLA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PREVALENCE; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; BACTERIAL INFECTION; BACTERIUM; CLINICAL TRIAL; DRUG EFFECT; ENTEROCOCCUS; FEMALE; HOSPITAL; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; PSEUDOMONAS; UNITED STATES;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BACTERIA; BACTERIAL INFECTIONS; CHICAGO; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; HOSPITALS; HUMANS; INPATIENTS; KLEBSIELLA; MALE; MARYLAND; MIDDLE AGED; PREVALENCE; PSEUDOMONAS; RETROSPECTIVE STUDIES; STAPHYLOCOCCUS AUREUS;

EID: 76249091681     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp349     Document Type: Article

References (16)

1. Saviteer SM, Samsa GP, Rutala WA. Nosocomial infections in the elderly. Increased risk per hospital day. Am J Med 1988; 84: 661-6.
2. McGarry SA, Engeman JJ, Schmader K et al. Surgical-site infection due to Staphylococcus aureus among elderly patients: mortality, duration of hospitalization, and cost. Infect Control Hosp Epidemiol 2004; 25: 461-7.
3. Niclaes L, Buntinx F, Banuro E et al. Consequences of MRSA carriage in nursing home residents. Epidemiol Infect 1999; 122: 235-9.
4. Morrison L, Stolarek I. Does MRSA affect patient outcomes in the elderly? A retrospective pilot study. J Hosp Infect 2000; 45: 169-71.
5. Washio M, Kiyohara C, Hamada T et al. The case fatality rate of methicillin-resistant Staphylococcus aureus (MRSA) infection among the elderly in a geriatric hospital and their risk factors. Tohoku J Exp Med 1997; 183: 75-82.
6. Eveillard M, Ernst C, Cuviller S et al. Prevalence of methicillin-resistant Staphylococcus aureus carriage at the time of admission in two acute geriatric wards. J Hosp Infect 2002; 50: 122-6.
7. Hori S, Sunley R, Tami A et al. The Nottingham Staphylococcus aureus population study: prevalence of MRSA among the elderly in a university hospital. J Hosp Infect 2002; 50: 25-9.
8. Anderson DJ, Engemann J, Harrell LJ et al. Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae. Antimicrob Agents Chemother 2006; 50: 1715-20.
9. Lodise TP, McKinnon PS, Swiderski L et al. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003; 36: 1418-23.
10. Wiener J, Quinn JP, Bradford PA et al. Multiple antibioticresistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999; 281: 517-23.
11. Clinical and Laboratory Standards Institute. Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data-Second Edition: Approved Guideline M39-A2. CLSI, Wayne, PA, USA, 2005.
12. Herold BC, Immergluck LC, Maranan MC et al. Communityacquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998; 279: 593-8.
13. Safdar N, Handelsman J, Maki DG. Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis. Lancet Infect Dis 2004; 4: 519-27.
14. Chamot E, Boffi El Amari E, Rohner P et al. Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother 2003; 47: 2756-64.
15. Lautenbach E, Strom B, Nachamkin I et al. Longitudinal trends in fluoroquinolone resistance among Enterobacteriaceae isolates from inpatients and outpatients, 1989-2000: differences in the emergence and epidemiology of resistance across organisms. Clin Infect Dis 2004; 38: 655-62.
16. Binkley S, Fishman NO, LaRosa LA et al. Comparison of unit-specific and hospital-wide antibiograms: potential implications for selection of empirical antimicrobial therapy. Infect Control Hosp Epidemiol 2006; 27: 682 7.